Whistleblowers Blog
-
Is Ranbaxy the Tip of the Iceberg?
May 22
Posted by: Reuben Guttman | Number of Comments: Be the first to Comment
Category: Whistleblowers Blog | Date Posted: Wednesday, May 22nd, 2013
As a result of a 2007 lawsuit initiated by a whistleblower under the U.S. Federal False Claims Act, Ranbaxy USA, Inc., a subsidiary of Indian generic pharmaceutical manufacture Ranbaxy Laboratories, Ltd., has agreed to pay the United States Government and multiple state governments the sum of $350 million to resolve civil claims.
Ranbaxy USA also plead guilty to three felony Food, Drug and Cosmetics Act counts, and four felony counts of knowingly making false statements to the U.S. Food and Drug Administration. Ranbaxy agreed to a crimina…
-
Psychic Investing
May 20
Posted by: David Fischer | Number of Comments: Be the first to Comment
Category: Whistleblower Articles, Whistleblower News, Whistleblowers Blog, Whistleblowing | Date Posted: Monday, May 20th, 2013
This post was written by our own Justin Victor.
Last month the SEC announced that it had filed a civil action against Sean Morton, an individual who engaged in a multi-million dollar investment scheme premised on Mr. Morton’s self-proclaimed psychic abilities. Mr. Morton solicited potential investors in one of his several investment companies claiming that he would be able to use his psychic powers to provide investment guidance to his investing team, touting fictitious success in predicting previous rises and falls in the stock market. …
-
If You Cannot Change Label, Change The Guidelines
May 17
Posted by: David Fischer | Number of Comments: Be the first to Comment
Category: Federal False Claims Acts, Whistleblower Articles, Whistleblower News, Whistleblowers Blog | Date Posted: Friday, May 17th, 2013
The Washington Post has a lengthy article in today’s paper regarding the extensive financial ties and conflicts of interest between the American Psychiatric Association (APA), the publisher of the Diagnostic and Statistical Manual of Mental Disorders (DSM), and the pharmaceutical industry. Pharmaceutical companies have given substantial sums of money to the publisher as well as the doctors who serve on the committees that draft the DSM guidelines. Not surprisingly, the new DSM has numerous changes that benefit the pharmaceutical companies…
-
Off-Label Marketing After The Settlement
May 6
Posted by: David Fischer | Number of Comments: Be the first to Comment
Category: Federal False Claims Acts, Whistleblower Articles, Whistleblowers Blog, Whistleblowing | Date Posted: Monday, May 6th, 2013
The Los Angeles Times recently reported that off-label uses of modafinil has continued to rise a very rapid rate. Following up on a report in JAMA Internal Medicine, the LA Times reports:
… a group of researchers has shown that use of modafinil grew almost ten-fold between 2002 and 2009, with the steepest rise in uses not approved by the Food and Drug Administration.[The reseach summarized in JAMA Internal Medicine] found that over the years studied almost 90% of patients who were prescribed the medication did not have a diagnosis for …
-
Foreign Whistleblowers Hold Multi-Nationals Accountable and Get Rewarded For Their Efforts
May 6
Posted by: David Fischer | Number of Comments: Be the first to Comment
Category: Whistleblower Articles, Whistleblower News, Whistleblowers Blog, Whistleblowing | Date Posted: Monday, May 6th, 2013
This post was written by our own Justin Victor.
HELP WANTED! The United States government is seeking the help of individuals who have information about multi-national companies that pay bribes to foreign officials to get business, or cheat the United States out of taxes or the benefit of bargained for products or services. Those interested need not be citizens of the United States or reside in the United States to apply.
Though an ad like this sounds farfetched, the United States is effectively do this. As the United States struggles w… -
The False Claims Act, Foreign Made Goods And Antidumping Duties
Apr 17
Posted by: David Fischer | Number of Comments: Be the first to Comment
Category: Federal False Claims Acts, Whistleblower News, Whistleblowers Blog, Whistleblowing | Date Posted: Wednesday, April 17th, 2013
Two recent False Claims Act cases involving foreign made goods highlight the role of the False Claims Act when foreign made goods are sold to the United States government. The first case involved the sale of goods made in China to the government. In late March, the government and CDW-government (“CDW-G”) settled a False Claims Act case for $5.66 million. One of the settled claims was that CDW-G (a subsidiary of CDW Corp.), “sold products to the United States that were manufactured in China and other countries that are prohibited…
-
Looking for Market Integrity in China
Apr 2
Posted by: Reuben Guttman | Number of Comments: Comments Off
Category: Whistleblowers Blog | Date Posted: Tuesday, April 2nd, 2013
Economic forces globally are driving conformity in a wide range of practices, says Reuben Guttman.
In Hong Kong’s financial district, high end stores like Cartier, Rolex and Burberry outnumber fast food chains like McDonalds and KFC, while up north on Nanjing Xi Lu road in Shanghai, that city’s bustling version of Fifth Avenue, has become a haven for the world’s most high end retailers. With political and cultural difference tempered by economic goals, Hong Kong and mainland China are searching for mechanisms to create greater integrity …
-
The new global legal norms
Mar 22
Posted by: Reuben Guttman | Number of Comments: Comments Off
Category: Whistleblowers Blog | Date Posted: Friday, March 22nd, 2013
As multinationals move around the globe, legal systems are cross-pollinated. China is a case in point, says Reuben Guttman who has just returned from an event in Shanghai dealing with securities dereliction.
On a Saturday afternoon this month, I was part of a team of four faculty members from Emory University Law School’s Center for Advocacy and Dispute Resolution participating in a training dialogue with Shanghai financial fraud prosecutors. The topic of the training was investigation and prosecution of insider trading cases.The s…
-
Justice Takes Side of Landis
Feb 26
Posted by: Reuben Guttman | Number of Comments: Comments Off
Category: Whistleblowers Blog | Date Posted: Tuesday, February 26th, 2013
Washington, DC — It looks like the false claims case against Lance Armstrong, which was brought by Floyd Landis, will finally see the light of day.
It is reported that the United States Department of Justice has decided to intervene in the case against Armstrong.
Landis, who brought suit as a whistleblower under the Federal False Claims Act, alleged that Armstrong participated in a scheme to cause the United States Postal Service to wrongfully pay out money to his Tour de France teams.
The apparent decision by the United States Depart…
-
Judge Scheindlin Limits Reach Of FCPA Jurisdiction
Feb 21
Posted by: Jonathan Kass | Number of Comments: Comments Off
Category: Whistleblowers Blog | Date Posted: Thursday, February 21st, 2013
On Tuesday, Judge Shira Scheindlin of the U.S. District Court for the Southern District of New York dismissed all claims asserted against Herbert Steffen, a 74 year old citizen of Munich, Germany and former CEO of Siemens S.A. Argentina (“Siemens”), a German company, in connection with a scheme to bribe Argentine officials. Specifically, the complaint alleged that, through relationships with people in Argentina, Steffen facilitated Siemens’ agreement to pay various officials within the Argentine government approximately $100 million to …